309.90
0.00
(0.00%)
At close: April 16 at 5:32:14 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 23 | 22 | 29 | 29 |
| Avg. Estimate | 5.69B | 5.93B | 24.53B | 26.41B |
| Low Estimate | 5.54B | 5.84B | 24.19B | 25.27B |
| High Estimate | 5.81B | 6.06B | 24.93B | 27.12B |
| Year Ago Sales | 5.24B | 5.42B | 22.59B | 24.53B |
| Sales Growth (year/est) | 8.58% | 9.39% | 8.57% | 7.66% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SYK.VI | -- | -- | -- | -- |
| S&P 500 | 6.79% | 5.59% | 9.06% | 14.11% |
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 3/21/2025 |
| Maintains | JMP Securities: Market Perform to Market Perform | 2/18/2025 |
| Maintains | Barclays: Overweight to Overweight | 2/10/2025 |
| Maintains | Goldman Sachs: Neutral to Neutral | 1/30/2025 |
| Maintains | Truist Securities: Hold to Hold | 1/30/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 1/29/2025 |